Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001327363-06-000001
Filing Date
2006-02-14
Accepted
2006-02-14 17:04:23
Documents
1
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 3419
  Complete submission text file 0001327363-06-000001.txt   5497
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O NABI BIOPHARMACEUTICALS 5800 PARK OF COMMERCE BLVD NW BOCA RATON FL 33487 5619895800
FAHIM RAAFAT E F (Reporting) CIK: 0001271999 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-04829 | Film No.: 06616790